IVBXF(IVBXF)
IVBXF
No analyst ratings available
No analyst price targets available for IVBXF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $18.77B | $23.66B | $28.07B | $35.84B | $45.39B |
| Low | $16.68B | $18.94B | $23.59B | $30.11B | $38.15B |
| High | $24.67B | $27.51B | $34.57B | $44.12B | $55.89B |
| EBITDA Avg | $-3.36B | $-4.24B | $-5.03B | $-6.42B | $-8.14B |
| Low | $-4.42B | $-4.93B | $-6.20B | $-7.91B | $-10.02B |
| High | $-2.99B | $-3.40B | $-4.23B | $-5.40B | $-6.84B |
| EBIT Avg | $-4.32B | $-5.45B | $-6.47B | $-8.26B | $-10.46B |
| Low | $-5.68B | $-6.34B | $-7.96B | $-10.17B | $-12.88B |
| High | $-3.84B | $-4.36B | $-5.43B | $-6.94B | $-8.79B |
| Net Income Avg | $2.15B | $3.67B | $5.10B | $7.80B | $13.26B |
| Low | $1.71B | $2.90B | $4.04B | $6.18B | $10.50B |
| High | $2.80B | $4.77B | $6.63B | $10.15B | $17.24B |
| EPS Avg | $1.24 | $2.11 | $2.93 | $4.48 | $7.61 |
| Low | $0.98 | $1.67 | $2.32 | $3.55 | $6.03 |
| High | $1.61 | $2.74 | $3.81 | $5.83 | $9.90 |
| Analysts (Rev / EPS) | 28 / 1 | 28 / 1 | 17 / 1 | 22 / 1 | 26 / 1 |